Home  |   Contact  |  Locations
Home > Knowledge > Clinical Studies > Current clinical studies > Plasma Volume Replacement


 

Plasma Volume Replacement

  • Clinical studies Plasma Volume Replacement

  • HES 130
    Prospective, controlled, single-blind, bicentric, randomized study on the safety of HES 130/0.42 comb. with a balanced electrolyte solution vs. 5% albumin comb. with an unbalanced electrolyte solution (NaCl 0.9%) in patients with compensated renal failure
  • HES 130
    Infusion of Venofundin® 6% or Tetraspan® 6% in Paediatric Patients aged up to 12 Years
  • HES 130
    Evaluation on the safety profile of Venofundin® 6% and Tetraspan® 6% in the Asian-Pacific Region
  • HES 130
    Perioperative Blood Volume Changes Caused by Hemorrhage and Fluid Therapy During Urologic Surgery

Our Philosophy: Sharing Expertise

Our goal is to acquire, preserve and expand knowledge for the healtcare market.

Your ideas are invaluable to us

Do you have any suggestions or ideas for new products or product improvements?